Wayne State University

AIM HIGHER

Human Investigation Committee

IRB Membership

IRB M1 Membership List

IRB MP2 Membership List

IRB B3 Membership List

IRB MP4 Membership List

IRB CTS1 Membership List

IRB PH1 Membership List

The HIC Chair is charged to review and approve new protocols and amendments to existing protocols that meet criteria for expedited review, and grant exemptions for research submissions that meet the rigid standards thereof.  The HIC Chair, or Vice Chair, is required to manage activities associated with applications for Single Time Use of a Test Article, so-called “compassionate use”. The HIC Chair is also named, and his/her telephone number listed on all WSU and Affiliate consent forms, as the contact person for research questions that may arise from study participants.

The HIC is comprised of (1) six distinctly specialized subsidiary IRBs, (2) support staff that is composed, in part, of research compliance administrators, a compliance officer and an education coordinator.

Adult and Pediatric Behavioral/Social Science Research

The Behavioral IRB (B3) is responsible for reviewing all behavioral and social science research in adults and minors. This committee convenes on the third Thursday of the month. Please consult HIC meeting dates and submission deadlines for additional information.

Adult and Pediatric Biomedical Research

There are four IRB's that review medical protocols involving adult participants (M1, MP2, MP4, and CTS1). Three of these IRB's (MP2, MP4 and CTS1) are qualified to review research involving minors (individuals younger than 18 years of age).

The M1 IRB convenes on the first Thursday of the month, MP2 convenes on the second Thursday of the month, and MP4 convenes on the fourth Thursday of the month. CTS1 meets as needed when a new submission specifies this review or an amendment or continuation is submitted by a previously approved CTS1 protocol.  Please consult HIC meeting dates and submission deadlines for additional information.
 

New M1 Electronic Full Board IRB Submissions

Please click on the following link to view the announcement regarding the new M1 electronic submission requirements:

M1 New Submissions

 

New IRB for Phase I Clinical Trials

The HIC has added a new committee (“PH1”) that specializes in the review of industry-sponsored Phase I clinical trials. Effective immediately, all new HIC submissions for industry-sponsored Phase I trials must be submitted to this new committee following the procedure described below. There are three objectives of this initiative: rapid turnaround of submissions; support for investigators, including new investigators, to increase their activities in this area of clinical research; and enhancement of some of the aims of the Clinical and Translational Science Award (CTSA) initiative. 
PH1 features weekly meetings and a rapid turnaround of submissions. All communications will be electronic. Submissions must use the current HIC forms available on the HIC website. The committee’s assistant, Ms. Barbara Lloyd, will receive submissions electronically at PH1board@wayne.edu, thoroughly pre-review them for completeness and clarity, and work closely with the investigator to optimize the submission for review by PH1. Memos of the committee’s decisions will be prepared quickly and be provided electronically to the investigator within days of the meeting. 
In order to provide these services, there are fees over and above the usual clinical trials fees charged by the HIC (FY 2009 PH1 fees).   For more information, please contact Barbara Lloyd at blloyd@med.wayne.edu or the Director- Responsible Conduct of Research, Gayle Kusch, at gayle.kusch@wayne.edu.